It is extremely hard for the average citizen to understand what the “state of the science” is on many issues. We can all type our queries about a particular topic into Google but, when we get the flood of results, most of us are not trained to be able to (a) understand the complicated statistical methodologies employed in many research studies, (b) compare studies and evaluate their strength relative to each other, or (c) assess what the preponderance of the evidence is across tens or even hundreds of studies.
On this episode of the Utterly Moderate Podcast, we are joined by Dr. Sallie Baxendale to help us think about how we might make such judgements. She also goes into detail about ways in which the scientific process can go wrong, as it has been in some areas of gender-affirming care in recent years, as Joshua Cohen discusses in Forbes:
“In the U.S., a politically partisan divide is shaping up between states that allow for and guarantee access to youth gender-affirming care and states that ban such treatment altogether. Twenty-two states have passed bans on the use of cross-sex hormones, puberty blockers and surgery in minors.
In Europe political divisions on this topic aren’t nearly as conspicuous as they are in the U.S. Rather, the debate is much more fact-based. An increasing number of countries have conducted systematic reviews of evidence to determine the benefits and risks of puberty blockers and cross-sex hormones. And the findings from these reviews—that the certainty of benefits is ‘very low’—have informed changes in policy regarding treatment of gender incongruence in minors. . .
All things considered, according to European health authorities and medical experts, there isn’t yet a medical consensus for the use of pharmaceutical and surgical interventions in gender dysphoric minors.
And so authorities are ‘tapping the brakes,’ shifting from care which prioritizes access to pharmaceutical and surgical interventions, to a less medicalized and more conservative approach that addresses possible psychiatric comorbidities. . .
In the U.S., on the other hand, talk of introducing guardrails like the ones being incorporated in Europe is sometimes met with being branded ‘transphobic’ or a ‘science denier.’”
You can read about Dr. Baxendale’s own troubling experiences with this field of research in her recent UnHerd article.
Dr. Sallie Baxendale is a professor of clinical neuropsychology at the University College of London’s Institute of Neurology. She has over three decades of clinical experience working with people with epilepsy in London and Oxford, is the current chair of the International League Against Epilepsy Diagnostic Methods Commission, and serves on the Board of Governors for the International Neuropsychological Society.
As you listen to this fascinating episode, also make sure to subscribe to our FREE NEWSLETTER!
-------------------
Episode Audio:
- "Air Background Corporate" by REDCVT (Free Music Archive)
- "Please Listen Carefully" by Jahzzar (Free Music Archive)
- "Last Dance" by Jahzzar (Free Music Archive)
- “Happy Trails (To You)” by the Riders in the Sky (used with artist’s permission)
37 m